Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MLEC Stock Forecast 2026-2027
$8.90
Current Price
$6.46M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MLEC Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
MLEC Price Momentum
-14.2%
1 Week Change
+25.2%
1 Month Change
-93.5%
1 Year Change
+132.4%
Year-to-Date Change
-94.3%
From 52W High of $157.05
+189.4%
From 52W Low of $3.08
📊 TOP ANALYST CALLS
Did MLEC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Moolec Science is one of their latest high-conviction picks.
Latest MLEC Stock Price Targets & Analyst Predictions
MLEC has shown a year-to-date change of 132.4% and a 1-year change of -93.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MLEC. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MLEC Analyst Ratings
1
Buy
0
Hold
0
Sell
MLEC Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $8.90
Latest MLEC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MLEC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 30, 2024 | Maxim Group | Anthony Vendetti | Buy | Initiates | $6.00 |
| Nov 22, 2022 | Cantor Fitzgerald | Overweight | Upgrade | $N/A | |
| Oct 20, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Sep 26, 2022 | Wedbush | Outperform | Maintains | $N/A | |
| Sep 7, 2022 | Capital One | Overweight | Initiates | $N/A |
Moolec Science SA (MLEC) Competitors
The following stocks are similar to Moolec Science based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Moolec Science SA (MLEC) Financial Data
Moolec Science SA has a market capitalization of $6.46M with a P/E ratio of 0.0x. The company generates $333.61M in trailing twelve-month revenue with a 37.7% profit margin.
Revenue growth is +69.7% quarter-over-quarter, while maintaining an operating margin of -39.5% and return on equity of +134.5%.
Valuation Metrics
Market Cap
$6.46M
Enterprise Value
$252.57M
P/E Ratio
0.0x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
+69.7%
Gross Margin
-25.5%
Operating Margin
-39.5%
Net Margin
+37.7%
EPS Growth
+948.3%
Financial Health
Cash/Price Ratio
+40.0%
Current Ratio
1.5x
Debt/Equity
7.9x
ROE
+134.5%
ROA
-54.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Moolec Science SA (MLEC) Business Model
About Moolec Science SA
What They Do
Produces sustainable food ingredients using molecular farming.
Business Model
Moolec Science SA generates revenue by developing and selling innovative food ingredients and nutritional products made through molecular farming and precision fermentation. Its offerings include engineered crops and oils for various applications, catering to markets such as pet food, human nutrition, and dietary supplements.
Additional Information
Founded in 2020 and headquartered in Luxembourg, the company operates in the United States, Europe, and South America, focusing on scalable, bio-based ingredients that enhance crop efficiency while mimicking animal protein functionality. Its products address the growing demand for sustainable solutions in the food-tech and life sciences sectors.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
52
CEO
Mr. Gaston Paladini M.B.A.
Country
Cayman Islands
IPO Year
2023
Website
www.moolecscience.comMoolec Science SA (MLEC) Latest News & Analysis
Latest News
Quick Summary
Moolec Science Limited announced successful industrialization of its GLASO1 safflower platform, achieving 45% GLA concentration and validating performance for commercial deployment.
Why It Matters
Successful industrialization of the GLASO1 platform and high-purity GLA output enhance Moolec's growth potential, signaling strong future revenue streams and competitive positioning in the food industry.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Moolec Science Limited announced a breakthrough in producing animal proteins in plants, achieving stable expression of bovine myoglobin in pea seeds through a collaboration with a U.S. academic institution.
Why It Matters
Moolec's breakthrough in producing animal proteins in plants could disrupt the food industry, potentially increasing demand for its technology and boosting stock value.
Source: Accesswire
Market Sentiment:
Neutral
Moolec Science Achieves One of the Highest Commercial-Scale GLA Concentrations From U.S. GLASO1 Crushing
2 months ago
Quick Summary
Moolec Science Limited announced positive results from its U.S. GLASO1 safflower platform, achieving GLA concentrations of about 45%, marking a significant operational milestone for its molecular farming efforts.
Why It Matters
Positive results from Moolec's safflower platform boost confidence in its commercial viability, potentially enhancing revenue streams and market position in the protein solutions sector.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
The program achieved oil with approximately 45% gamma-linolenic acid post U.S. crushing, noted as one of the highest levels reported commercially.
Why It Matters
High gamma-linolenic acid levels in oil can enhance market demand and pricing, potentially boosting the company's profitability and attractiveness to investors.
Source: Benzinga
Market Sentiment:
Positive
Moolec Science Granted Continued Listing on Nasdaq Subject to Hearings Panel Conditions
3 months ago
Quick Summary
Moolec Science S.A. has received approval from the Nasdaq Hearings Panel to continue its listing on Nasdaq, contingent upon meeting specific conditions.
Why It Matters
Moolec Science’s continued Nasdaq listing signals investor confidence and potential for growth, while compliance with conditions may impact future stock performance and investor sentiment.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Moolec Science S.A. received a Nasdaq exception until June 29, 2026, to meet stockholders' equity requirements, with specific disclosure conditions to be followed.
Why It Matters
Moolec Science's extension to meet Nasdaq's stockholders' equity requirement indicates potential stability, which could influence investor confidence and stock performance.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About MLEC Stock
What is Moolec Science SA's (MLEC) stock forecast for 2026?
Analyst forecasts for Moolec Science SA (MLEC) are not currently available. The stock is trading at $8.90.
Is MLEC stock a good investment in 2026?
According to current analyst ratings, MLEC has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $8.90. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MLEC stock?
Price predictions from Wall Street analysts for MLEC are not currently available. The stock is trading at $8.90.
What is Moolec Science SA's business model?
Moolec Science SA generates revenue by developing and selling innovative food ingredients and nutritional products made through molecular farming and precision fermentation. Its offerings include engineered crops and oils for various applications, catering to markets such as pet food, human nutrition, and dietary supplements.
What is the highest forecasted price for MLEC Moolec Science SA?
Price targets from Wall Street analysts for MLEC are not currently available. The stock is trading at $8.90.
What is the lowest forecasted price for MLEC Moolec Science SA?
Price targets from Wall Street analysts for MLEC are not currently available. The stock is trading at $8.90.
What is the overall MLEC consensus from analysts for Moolec Science SA?
The overall analyst consensus for MLEC is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are MLEC stock price projections?
Stock price projections, including those for Moolec Science SA, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 9, 2026 10:27 AM UTC